Scott Peruski

Scott Peruski is a Senior Scientist at Genentech, where they focus on developing novel anti-obesity medications through structure-based drug design. They completed a PhD at the University of Houston under Dr. Scott Gilbertson, where their dissertation centered on synthetic approaches toward serotonin 2A and 2C agonists and antagonists related to drug addiction. Scott has also held various internships and roles in organizations such as the American Embassy Guatemala, the Centers for Disease Control and Prevention, and Carmot Therapeutics, contributing to projects in narcotics, infectious diseases, and pharmaceutical synthesis.